Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France.
Avouac J, Moltó A, Abitbol V, Etcheto A, Salcion A, Gutermann L, Klotz C, Elhai M, Cohen P, Soret PA, Morin F, Conort O, Chast F, Goulvestre C, Jeunne CL, Chaussade S, Kahan A, Roux C, Allanore Y, Dougados M. Avouac J, et al. Among authors: goulvestre c. Semin Arthritis Rheum. 2018 Apr;47(5):741-748. doi: 10.1016/j.semarthrit.2017.10.002. Epub 2017 Oct 5. Semin Arthritis Rheum. 2018. PMID: 29102156
Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practice.
Lauret A, Moltó A, Abitbol V, Gutermann L, Conort O, Chast F, Goulvestre C, Le Jeunne C, Chaussade S, Roux C, Batteux F, Dougados M, Allanore Y, Avouac J. Lauret A, et al. Among authors: goulvestre c. Semin Arthritis Rheum. 2020 Dec;50(6):1449-1456. doi: 10.1016/j.semarthrit.2020.02.007. Epub 2020 Feb 19. Semin Arthritis Rheum. 2020. PMID: 32268935
Doctor's aptitude for switching from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: experience from a single French rheumatology tertiary care center.
Al Tabaa O, Etcheto A, Dumas S, Batteux F, Goulvestre C, Moltó A, Miceli-Richard C, Dougados M. Al Tabaa O, et al. Among authors: goulvestre c. Eur J Clin Pharmacol. 2021 Jan;77(1):25-33. doi: 10.1007/s00228-020-02957-2. Epub 2020 Sep 5. Eur J Clin Pharmacol. 2021. PMID: 32888052
Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis: a systematic literature review and retrospective study.
Hilliquin S, Herrou J, Gutermann L, Goulvestre C, Avouac J, Henry J, Hilliquin P, Dougados M, Moltó A. Hilliquin S, et al. Among authors: goulvestre c. Clin Exp Rheumatol. 2023 Jul;41(7):1417-1426. doi: 10.55563/clinexprheumatol/1h6h71. Epub 2022 Dec 7. Clin Exp Rheumatol. 2023. PMID: 36533995 Free article.
50 results